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Abstract
Background and purpose: Accurate epidemiological information is essential for the im-
proved understanding of dystonia syndromes, as well as better provisioning of clinical 
services and providing context for diagnostic decision- making. Here, we determine epi-
demiological, social deprivation, and mortality characteristics of adult- onset idiopathic 
dystonia in the Welsh population.
Methods: A retrospective population- based cohort study using anonymized electronic 
health care data in Wales was conducted to identify individuals with dystonia between 1 
January 1994 and 31 December 2017. We developed a case- ascertainment algorithm to 
determine dystonia incidence and prevalence, as well as characterization of the dystonia 
cohort, based on social deprivation and mortality.
Results: The case- ascertainment algorithm (79% sensitivity) identified 54,966 cases; of 
these cases, 41,660 had adult- onset idiopathic dystonia (≥20 years). Amongst the adult- 
onset form, the median age at diagnosis was 41 years, with males significantly older at 
time of diagnosis compared to females. Prevalence rates ranged from 0.02% in 1994 to 
1.2% in 2017. The average annual incidence was 87.7/100,000/year, increasing from 
49.9/100,000/year (1994) to 96.21/100,000/year (2017). In 2017, people with dystonia 
had a similar life expectancy to the Welsh population.
Conclusions: We have developed a case- ascertainment algorithm, supported by the in-
troduction of a neurologist- reviewed validation cohort, providing a platform for future 
population- based dystonia studies. We have established robust population- level preva-
lence and incidence values for adult- onset idiopathic forms of dystonia, with this reflect-
ing increasing clinical recognition and identification of causal genes. Underlying causes of 
death mirrored those of the general population, including circulatory disorders, respira-
tory disorders, cancers, and dementia.
K E Y W O R D S
dystonia, incidence, mortality, prevalence, socioeconomic factors
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INTRODUC TION
Dystonia is a hyperkinetic movement disorder characterized by sus-
tained muscle contractions, producing repetitive movements and 
abnormal postures, impacting both physical and social function-
ing [1,2]. Accurate epidemiological information is essential for the 
improved understanding of dystonia syndromes, as well as better 
provisioning of clinical services and providing context for diagnostic 
decision- making. However, the true prevalence of dystonia remains 
largely unknown, with notable variation in reported rates world-
wide, depending on disorder subtype, cohort ethnicity, and study 
design [3].
A recent meta- analysis estimated the global prevalence of dys-
tonia to be 16.43 per 100,000 [4], although work to date suggests 
that this may vary geographically. Northern European countries, 
the USA, and Colombia have higher rates of prevalence than those 
observed in Asia and Southern Europe [5– 11]. Similar variation 
between ethnicities has also been observed in rates of incidence. 
Higher rates of adult- onset idiopathic, isolated focal cervical dysto-
nia (AOIFCD) have been identified amongst Caucasian populations 
[12,13]. Higher rates of early- onset (≤28 years old) idiopathic torsion 
dystonia (5 per 100,000) were identified amongst Ashkenazi Jewish 
populations, in part due to the founder effects of genetic forms of 
dystonia [14]. Prevalence estimates are also dependent on age. The 
prevalence of early- onset dystonia (<20 years) is estimated to be be-
tween 0.3 and 5 cases per 100,000 [15,16], whereas the prevalence 
of adult- onset (>20 years) dystonia is between 0.3 and 732 cases per 
100,000 [3,15,17]. Table 1 summarizes dystonia prevalence studies.
Different study types have been used to determine the epide-
miological characteristics of dystonia. These have included service- 
based, linkage record- based, and population- based studies. Studies 
also vary in their reliance upon patient- reported diagnoses and clin-
ical confirmation (Table 1), possibly explaining the variation in ob-
served prevalence rates. Current estimates of dystonia prevalence 
are also likely to be underestimates, due to a combination of lack 
of recognition, underdiagnosis, and the limited number of patients 
seeking treatment [4,17].
Recent advances in record- linked population data repositories 
have led to increased opportunities for population- based studies, 
providing more detailed epidemiological data across a range of neu-
rological disorders [18– 20]. There is a specific need to apply this 
population- based approach to dystonia syndromes, particularly in 
relation to adult- onset focal syndromes [21]. Use of data from several 
sources may address conflicting epidemiological estimates, and also 
has the potential to generate detailed information over several years 
and across diverse geographic areas, which is currently lacking in the 
field. The Secure Anonymised Information Linkage (SAIL) Databank 
contains anonymized, routinely collected data for the Welsh popu-
lation (3.15 million [2019]) [22]. It is one of the most accessible and 
broadest sources of anonymized data in the world, covering an ex-
tensive percentage of the Welsh population (100% of Welsh hospi-
tals and ~80% of general practitioners). SAIL also provides complete 
data linkage of social, education, and health care data, enabling a 
more comprehensive understanding of patient care, and allowing 
for analysis of multifactorial relationships. In comparison, another 
UK primary dataset (Clinical Practice Research Datalink) has linkage 
to only around 10% of English general practices (GPs) [23]. Other 
linked population data include those in Scandinavia and Australia. 
However, those in Australia are managed at a state level, including 
data collections, individual data linkage units, and ethics commit-
tees. The Lumos programme, the first state- wide database linked 
to GP records throughout New South Wales (NSW), was recently 
established and covers 16% of the NSW population [24].
Using SAIL, we aimed to derive an algorithm to identify individ-
uals diagnosed with dystonia, and to establish key epidemiological 
characteristics, including links to deprivation and causes of mortality.
METHODS
Study design and data sources
Using a retrospective population- based cohort study design, 
we identified patients diagnosed with dystonia within the SAIL 
Databank (Swansea University, UK: www.saild ataba nk.com). SAIL is 
a databank containing anonymized, electronic, person- based health, 
social, and education data about the population of Wales. Clinical 
and demographic data from multiple data- providing organizations, 
including Welsh General Practices, Public Health Wales National 
Health Service (NHS) Trust, Digital Health and Care Wales, HDR 
Wales, Welsh Government, Office for National Statistics, Welsh 
Ambulance Service NHS Trust, and Intensive Care National Audit & 
Research Centre, are anonymized and encrypted by a trusted third 
party, the NHS Wales Informatics Service, and transferred directly 
to SAIL. Individuals are reliably matched against records and an-
onymized using a unique Anonymous Linking Field. This matching 
algorithm has demonstrated high specificity (>99%) and sensitivity 
(>95%) and enables linkage across different datasets at a person- 
based level [25,26].
Our study population was formed from primary care (Welsh 
Longitudinal General Practice dataset) and secondary care (Patient 
Episode Database for Wales [PEDW] and Outpatient Dataset 
[OPD]) between January 1994 (utilization of the reference popu-
lation and the first monogenic form of dystonia identified in 1994 
[DYT5a]) [27] and December 2017. At the time of analysis, primary 
care and secondary care data were available for ~80% and 100% of 
the Welsh population, respectively. Time coverage varies between 
GPs, and there are dates with higher periods of data capture within 
SAIL, for example, 2004– 2007. Inpatient (PEDW) and outpatient 
(OPD) datasets commenced in 1997 and 2004, respectively. We 
recorded demographic characteristics including age, sex, GP reg-
istration history, and deprivation. We measured deprivation using 
the Welsh Index of Multiple Deprivation (WIMD) obtained from the 
Welsh Demographic Service Dataset, which contains administrative 
data on all persons registered with a primary care practice in Wales 
[28]. Date and cause of death (if applicable) were obtained from the 
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Annual District Death Extract (ADDE). Data were analysed from 
September 2020 to May 2021.
Reference population and diagnostic validation
Anonymized records from 90 patients with a confirmed diagnosis of 
AOIFCD were linked to records held in SAIL. Each participant was re-
cruited via the Welsh Movement Disorders Research Network Study 
(Research Ethics Committee reference: 14/WA/0017, Integrated 
Research Application System ID: 146495), was clinically assessed, and 
had their NHS records reviewed by a neurologist with expertise in 
movement disorders (K.J.P.). These patients formed the reference pop-
ulation for our derived cohort of individuals diagnosed with dystonia.
Sensitivity algorithm
A list of Read codes (version 2) and International Classification of 
Diseases, 10th Revision (ICD- 10) codes was selected and used to 
identify individuals with a primary and/or secondary dystonia diag-
nosis. All codes relevant to dystonia including diagnosis, symptoms, 
and therapy were reviewed by a clinical neurologist with movement 
disorder expertise. Code lists were created to maximize the posi-
tive predictive value, while maintaining a reasonable sensitivity. In 
a stepwise manner, Read codes that did not contribute to the iden-
tification of the reference cohort were removed. All ICD- 10 codes, 
excluding drug- induced dystonia, were used. Sensitivity analyses of 
Read codes are available in Table S1. A full list of the final Read and 
ICD- 10 codes is provided in Table 2.
Dystonia diagnosis
An individual was defined as having a diagnosis of dystonia if their 
GP or hospital record contained a Read version 2 or ICD- 10 code 
from the list of codes (Table 2). Dystonia subtypes were not mutually 
exclusive; an individual could have more than one dystonia subtype. 
Results from primary and secondary care extracts were combined 
to create a joined dystonia cohort. Individuals diagnosed with a po-
tential secondary cause of dystonia were excluded (Tables S2– S4) 
[29,30]. Our stringent exclusion criteria removed diagnostic codes 
linked with tremor (apart from dystonic tremor) and diagnoses that 
may include tremor as part of the phenotype. Medicine codes for all 
forms of dopaminergic therapy were also included in this exclusion 
algorithm, providing an additional mechanism to exclude degenera-
tive forms of tremor. Inclusion of the tremor code was shown to in-
crease the sensitivity of our patient identification algorithm by 6% 
(73%– 79%) in our validation cohort, allowing for recognition of dys-
tonic tremor as a form of primary dystonia, while limiting the pos-
sibility of including other forms of tremor.
Additionally, individuals were required to be resident in Wales 
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date recorded. Individuals born before 1 January 1900 and older 
than 100 years were excluded. Entry date into the cohort was the 
first date of a new dystonia diagnosis and the last date of follow- up 
was the earliest GP deregistration (from a contributing practice), 
date of death, or the end of the study period, whichever was first. 
Figure 1 summarizes how the dystonia cohort was derived.
We identified all dystonia cases in primary and secondary care 
datasets; however, further analysis including epidemiological, depri-
vation, and mortality characterization focuses on individuals with 
adult- onset idiopathic dystonia (≥20 years of age).
Incidence and prevalence
Estimates for prevalence and incidence were calculated annually for 
the study period (January 1994– December 2017). Prevalence was 
calculated by dividing the number of people diagnosed with dysto-
nia midyear (30 June) by the midyear population estimate. Incidence 
was calculated by dividing the number of newly diagnosed cases (no 
previous diagnosis) for that year by the midyear population estimate. 
The midyear population was estimated by the total number of Welsh 
residents with a recorded sex and age, registered to a GP on 30 June 
of that year.
Deprivation score
Deprivation scores were derived using WIMD 2014 quintiles accord-
ing to Lower Super Output Area (LSOA) of residence (2011). WIMD 
identifies and ranks all LSOAs in Wales from 1 (most deprived) to 
1909 (least deprived); each LSOA is then grouped into quintiles, with 
1 being the most deprived and 5 being the least deprived [28]. The 
WIMD quintile was assessed at three dates: study entry, time of dys-
tonia diagnosis, and exit date from the study (study end [December 
2017], deregistration from GP, moving out of Wales, or death).
Mortality
Date and underlying causes of death during the study period were 
determined from the ADDE. Underlying causes of deaths coded 
using ICD- 9 were converted to ICD- 10.
Statistical analysis
Data was analysed using R software (version 4.0.4). Where appli-
cable, a t- test or Mann– Whitney U- test was used to determine any 
TA B L E  2  ICD- 10 and read codes used to identify dystonia patients in hospital and general practice electronic records, respectively
Dystonia subtype ICD- 10 code Read code Read code description
Genetic torsion dystonia G24.1
Idiopathic torsion dystonia F136. Idiopathic torsion dystonia
F137. Symptomatic torsion dystonia
F137y Symptomatic torsion dystonia OS
F137z Symptomatic torsion dystonia NOS
F138. Fragment of torsion dystonia
F138z Torsion dystonia fragment NOS
Idiopathic nonfamilial dystonia G24.2
Idiopathic familial dystonia F1360 Idiopathic familial dystonia





Idiopathic Orofacial dystonia G24.4
Blepharospasm G24.5 F1380 Blepharospasm
Writer's cramp F1383 Organic writer's cramp
Myoclonic dystonia F13B. Myoclonic dystonia
Segawa syndrome F13C. Segawa syndrome
Other G24.8 Fyu24 [X]Other dystonia
Unspecified G24.9 Fyu2A [X]Dystonia, unspecified
F13X. Dystonia, unspecified
Tremor 1B22. Has a tremor
Abbreviations: [X], external causes of morbidity and mortality; ICD- 10, International Classification of Diseases, 10th Revision; NOS, not otherwise 
specified; OS, otherwise specified.
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significant difference in the median age at diagnosis and subtype 
of dystonia, and Wilcoxon signed- rank test was used to determine 
changes to WIMD quintile following diagnosis.
Ethics
This study design uses anonymized, routinely collected data and 
therefore does not require ethical approval and written informed 
consent. The SAIL independent Information Governance Review 
Panel, experts in information governance and members of the pub-
lic, approved this study (Reference: 0768).
RESULTS
Validating the dystonia diagnosis
The optimized case- ascertainment algorithm (Figure 1) had a diag-
nostic sensitivity of 79%, identifying 70 of 89 of the clinically con-
firmed reference population (one patient could not be identified 
within SAIL).
Dystonia cohort
A total of 54,966 patients were identified as having been diagnosed 
with dystonia between 1 January 1994 and 31 December 2017. Of 
these, 54,488 were identified from primary care (GP records) and 
478 from secondary care (hospital records). Of these, 41,660 were 
determined to have adult- onset symptoms (age ≥ 20 years) and 
13,306 young- onset forms of dystonia (age <20 years; Table 3). In 
adult- onset forms, the female:male ratio was 1.7:1. Fourteen cases 
had more than one dystonia diagnosis. The most common combina-
tion of diagnoses was cervical dystonia and unspecified (n = 8). No 
cases of idiopathic familial dystonia or Segawa syndrome were iden-
tified, irrespective of levodopa medication exclusion.
Prevalence and incidence rates
There were 32,662 patients diagnosed with adult- onset idiopathic 
dystonia at the midpoint of 2017, providing a crude prevalence of 
1.2% amongst the Welsh population. During the study period, 
41,660 new cases of adult- onset idiopathic dystonia were reported, 
giving a mean incidence of 87.6/100,000/year, varying between 
49.9/100,000/year in 1994 and 96.2/100,000/year in 2017. The 
maximum incidence was 112.7/100,000/year in 2006 (Figure 2a 
and Table S5). Dystonia incidence increased in males and females, 
23.5/100,000 to 62.6/100,000 (1994 and 2017), and 45.5/100,000 
to 95.1/100,000 (1994 and 2017), respectively.
Deprivation
At the time of diagnosis, adult- onset cases were equally distributed 
across deprivation quintiles (Table 3 and Figure 3b). There were no 
significant changes in deprivation quintile throughout the study 
 between entry into the dataset (during the study period) and di-
agnosis (median = 0, p < 0.01; Figure 3a), diagnosis and follow- up 
F I G U R E  1  Flow diagram of cohort development. Green, blue, and yellow boxes: primary and secondary health data records; purple 
boxes: dystonia cohort population; orange boxes: exclusion criteria; red boxes: sensitivity analysis. GP, general practice, ICD- 10, International 
Classification of Diseases, 10th Revision; OPD, Outpatient Dataset; PEDW, Patient Episode Database for Wales; SAIL, Secure Anonymised 
Information Linkage; WDSD, Welsh Demographic Service Dataset; WLGP, Welsh Longitudinal General Practice dataset; WOB, week of birth 
[Colour figure can be viewed at wileyonlinelibrary.com]
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(median = 0, p < 0.01; Figure 4a), and entry into the study and fol-
low- up (median = 0, p < 0.01).
Mortality
There were 4,315 deaths (10%) in the adult- onset dystonia co-
hort (Table 3). Distribution of mortality data by dystonia syn-
dromes, including the 10 most common causes of death, is shown 
in Figure 5.
DISCUSSION
Our longitudinal, nationwide population- based cohort study has 
combined anonymized electronic data derived from GP (family 
doctor/community health care) and hospital records for more than 
3.6 million Welsh individuals to estimate the prevalence and inci-
dence rates for dystonia and its multiple subtypes. We maintained 
terminology of Read and ICD- 10 codes for a true reflection of their 
use within primary and secondary care. Our case ascertainment al-
gorithm demonstrated an overall sensitivity of 79%, identifying 70 
of 89 of the clinically confirmed cases. The midyear point preva-
lence of adult- onset idiopathic dystonia in Wales increased from 
16.4/100,000 (0.02%) in 1994 to 1,219.8/100,000 (1.2%) in 2017, 
with an increase in annual incidence from 49.9/100,000 (1994) 
to 96.2/100,000 (2017). Individuals diagnosed with adult- onset 
idiopathic dystonia were found to be equally distributed across 
measures of socioeconomic deprivation at time of diagnosis, with 
no evidence of change in deprivation over time. There were 4,315 
deaths in those diagnosed with adult- onset idiopathic dystonia, 
with ischaemic heart disease, cerebrovascular diseases, pneumonia, 
bronchitis, emphysema, and other chronic obstructive pulmonary 
diseases being the most common causes of death.
Previous estimates of dystonia prevalence, from service- or 
population- based studies, have varied between 6.1 and 70.1 per 
100,000 in the former [31,32], to between 7.91 and 732 per 100,000 
in the latter [15,17]. However, these approaches are likely to intro-
duce bias, identifying only those seeking out or receiving clinical 
care, as well as underascertaining cases, suggesting that rates of 
dystonia within the population are higher than previously suggested 
[21]. In support of this, our results suggest an overall prevalence of 
dystonia syndromes of 1,219.8/100,000 (1.2%), which, given the un-
biased nature of the case identification, suggests a more accurate 
population- based value. The median age at diagnosis (42 years) and 
proportion of males to females (1:1.7) determined in this study are 
consistent with previous studies, suggesting that the cohort identifi-
cation criteria were appropriately applied.
Amongst population- based studies, two of the highest nota-
ble outliers estimated a prevalence of 732/100,000 (0.73%) and 
390/100,000 (0.39%) [6,17]. Previous UK- based studies have re-
ported prevalence rates of 38 per 100,000 in those diagnosed 
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over the same period [10,16,33– 35]. The UK study also used a 
linkage- based approach, ascertaining cases by reviewing hospital 
records, as well as recruiting individuals registered as members 
to the Dystonia Society, and via a postal survey [36]. Our study 
has expanded upon this using detailed linked data available across 
the whole of Wales. More recent epidemiological studies of dys-
tonia show a trend toward elevated estimates compared to the 
literature prior to 2012 [21], which may be in part due to an ageing 
population, increased clinical recognition of dystonia, and iden-
tification of an ever- expanding number of causative genes [37].
Three US- based studies have estimated the incidence of cervical 
dystonia between 0.8 and 1.18 per 100,000 person- years [5,12,38], 
and incidence rates of other types of dystonia varied between 0.2 
and 0.4/100,000 person- years [5]. As with the multiple factors 
F I G U R E  3  (a) Change in Welsh Index of Multiple Deprivation (WIMD) quintile and (b) number of cases per WIMD quintile at entry 
into dataset (during study period) and diagnosis by dystonia subtype in adult- onset forms. (i) Overall dystonia. (ii) Cervical dystonia. (iii) 
Tremor associated with dystonia. (iv) Blepharospasm. (v) Other/unspecified. Change in WIMD quintile = (WIMD quintile at time of diagnosis) 
– (WIMD quintile at end of follow- up). WIMD Quintile 1 is most deprived, and Quintile 5 is least deprived [Colour figure can be viewed at 
wileyonlinelibrary.com]
F I G U R E  2  Trends in (a) incidence and (b) prevalence for adult- onset idiopathic dystonia by sex and dystonia subtype. (i) Overall 
dystonia. (ii) Cervical dystonia. (iii) Tremor associated with dystonia. (iv) Blepharospasm (masked in 1994). (v) Other/unspecified (incidence 
masked <2004; prevalence masking in 1994 and 1995) [Colour figure can be viewed at wileyonlinelibrary.com]
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influencing prevalence rates, it is likely that these estimates are lower 
than true population values. In comparison, we found an average 
annual incidence of 87.65/100,000, increasing from 49.85/100,000 
cases (1994) to 96.21/100,000 (2017). New cases were highest be-
tween 2004 and 2008, ranging from 104.09 to 112.66 per 100,000. 
These dates coincide with a known period of higher data capture 
within SAIL [39], whereas electronic records prior to 2000 in the 
SAIL Databank are sparse, providing a likely explanation for the 
more marked increase in numbers after this time. However, rates 
have slowly decreased since 2011, plateauing at ~100/100,000. 
Elevated rates of incidence are consistent with increased recogni-
tion, awareness, and improved availability of neurological services.
Our study demonstrated that deprivation scores did not change 
following a diagnosis of dystonia, arguably an unexpected finding 
given the potential for dystonia to impact employment and social 
interaction. To our knowledge, there has been no research that di-
rectly investigates changes in deprivation, with previous studies 
that have included measures of this nature identifying conflicting 
findings. A population- based survey in India found no significant 
differences in dystonia prevalence estimates when comparing slum 
dwellers and non- slum dwellers, despite their socioeconomic dif-
ferences [9]. Other studies have also noted that dystonia affects 
employment, with pain and severity of symptoms impacting work 
status in up to 40% of cases [40]. However, given that many of the 
treatments typically used to manage motor symptoms, notably 
botulinum neurotoxin and deep brain stimulation (DBS), have been 
shown to improve quality of life, and reduce pain and motor symp-
tom severity, it is plausible that this may contribute to maintained 
working status [41,42]. Interestingly, increased rates of DBS surgery 
have been observed in the USA between 2002 (n = 2372) and 2014 
(n = 5260), with a similar trend likely in the UK [43].
To our knowledge, ours is the first study to assess mortality in 
patients with dystonia. Of the cohort, 10% died during the study pe-
riod, with a median age at death of 80 years. There was no evidence 
of a higher level of premature death (<75 years of age) amongst the 
dystonia cohort (35.9%), which was comparable to the rate in the 
general population in Wales (31.7%, 2017). Amongst our cohort, 
males and females had a median age at death (78 and 82 years, re-
spectively) comparable to the life expectancy in Wales (78.5 years 
and 82.3 years, 2017– 2019) [44]. Males diagnosed with other/un-
specified forms of dystonia and writer's cramp were younger than 
the expected median age (72 and 74 years, respectively), and both 
males and females (70 and 72.5 years) with idiopathic torsion dys-
tonia were younger at death. The most common causes of death 
included respiratory disorders, circulatory disorders, cancers, and 
dementia, in keeping with the leading causes of deaths registered 
in England and Wales (2017) [45]. Comparable causes of death were 
also noted amongst dystonia subtypes (Figure 5).
As with all record linkage- based studies there are several limita-
tions. First, those who have not sought medical attention, either in 
the community or hospital- based specialist care, will not be captured 
by this analysis.
Dystonia is primarily diagnosed in secondary care by a specialist, 
and subsequently coded in primary care by general practitioners. 
Our algorithm was 79% sensitive, with 74% of the reference pop-
ulation being identified from primary records alone. Although there 
is little incentive for GPs to subtype dystonia, in general, there is 
evidence to suggest that primary care coding is relatively accurate in 
the UK [46]. Several previous studies, using the SAIL database, have 
validated the accuracy of using these diagnosis codes for case ascer-
tainment of other neurological conditions [20,47,48]. However, cod-
ing practices may vary between GPs as well as having the potential 
F I G U R E  4  (a) Change in Welsh Index of Multiple Deprivation (WIMD) quintile and (b) number of cases per WIMD quintile at diagnosis 
and follow- up by dystonia subtype in adult- onset forms. (i) Overall dystonia. (ii) Cervical dystonia. (iii) Tremor associated with dystonia. (iv) 
Blepharospasm. (v) Other/unspecified. Change in WIMD quintile = (WIMD quintile at entry) – (WIMD quintile at time of diagnosis). WIMD 
Quintile 1 is most deprived, and Quintile 5 is least deprived [Colour figure can be viewed at wileyonlinelibrary.com]
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to change with time. Our validation cohort consisted of individuals 
seen in one specialist service, and it may be that these individuals 
were more likely to get a primary care dystonia code when compared 
to individuals seen in other services.
There is always the potential for diagnostic misclassification 
through coding. For example, we did not identify any cases of id-
iopathic familial dystonia. This likely reflects the focus on achieving 
the most accurate clinical diagnosis for the individual patient, with 
information relating to other affected family members not always 
being known to the patient and/or the treating clinician.
Including hospital inpatient and outpatient data, in addition to pri-
mary care data, provided only a small increase in case ascertainment sen-
sitivity (0.9%). This may be because hospital coding is primarily related to 
recording the admission or attendance, with the reasons for being admit-
ted and comorbidities being less frequently documented [20].
We were unable to obtain a measure of specificity for our case 
ascertainment algorithm in general and for dystonia subtypes, as we 
were unable to upload relevant negative control groups. It there-
fore remains possible that we included a proportion of cases without 
dystonia. However, we sought to account for this by applying strin-
gent exclusion criteria that would account for most known causes 
of acquired dystonia or misdiagnosis of dystonia. Lastly, deprivation 
is difficult to measure, and although the WIMD is one of the more 
comprehensive deprivation scores available, it does not cover every 
aspect of deprivation. It is also an area- based rather than individual- 
based measure of deprivation. It is therefore possible that an in-
crease in deprivation for an individual would not change their WIMD 
score if they did not change address. We may therefore lack recogni-
tion of social change in deprivation.
Our results indicate that prevalence and incidence rates of dys-
tonia are higher than previously estimated, 1,220/100,000/year 
(1.2%) and 96/100,000/year, respectively, potentially indicating 
more accurate population estimates given the unbiased nature of 
patient identification. We have shown that a diagnosis of dystonia 
F I G U R E  5  Mortality data of cases including leading underlying causes of death and proportions of death categorized by causes in 
adult- onset idiopathic dystonia. (a) General population in Wales (2017). (b) Overall dystonia. (c) Cervical dystonia. (d) Tremor associated with 
dystonia. (e) Blepharospasm. (f) Other/unspecified. COPD, Chronic Obstructive Pulmonary Disease, SSAF, symptoms, signs, and abnormal 
clinical and laboratory findings, not elsewhere classified [Colour figure can be viewed at wileyonlinelibrary.com]
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does not appear to have a detrimental impact on socioeconomic sta-
tus, with no changes in deprivation observed at follow- up. In addi-
tion, there was no evidence of decreased life expectancy and causes 
of underlying death, mirroring the Welsh leading causes of death. 
The findings from this work have important implications for patients, 
carers, health care providers, third sector organizations, and health 
care policy, with our case- ascertainment algorithm providing a plat-
form for application in future population- based dystonia studies.
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